Indivior Pharmaceuticals
INDV
INDV
290 hedge funds and large institutions have $3.89B invested in Indivior Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 97 increasing their positions, 86 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding
Funds holding: 258 → 290 (+32)
11% less capital invested
Capital invested by funds: $4.36B → $3.89B (-$468M)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
290
Holding in Top 10
7
Calls
$13.5M
Puts
$9.58M
Top Buyers
| 1 | +$74.6M | |
| 2 | +$46.4M | |
| 3 | +$42.1M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$38.8M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$27.4M |
Top Sellers
| 1 | -$74.8M | |
| 2 | -$64.9M | |
| 3 | -$60.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$57M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$55.9M |
